Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drape may shield heart doctors from radiation

NCT ID NCT06233578

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special drape called RADPAD can reduce radiation exposure for doctors performing heart catheterizations. Researchers measured radiation levels for doctors with and without the drape during 1,000 procedures. The goal is to see if this simple shield can make these common heart procedures safer for the medical team.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
RADPAD radiation protection drape
What this could lead to
If effective, this drape could become a standard tool to lower radiation exposure for doctors performing heart procedures, improving their long-term safety.
What could go wrong
This is a completed trial, but the results may not apply to all hospital settings or procedure types. The benefit may be small or vary by operator.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,000 people

The number who actually took part.

Started

Jan 2024

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Employees): * Proximal operator of a cardiac catheterization procedure as defined by the individual performing the procedure closest to the source of radiation. This may be either physician assistants of the CCL, fellows of cardiovascular disease, interventional cardiology fellows or attending interventional cardiologists at NYU Langone Hospital - Long Island. * Age ≥18 years * Willing and able to consent. Inclusion Criteria (Patient Cases): * Cardiac catheterization procedure at NYU Langone Hospital - Long Island. * Age ≥18 years of the patient undergoing cardiac catheterization. Exclusion Criteria (Employees): * Anyone unable or unwilling to give informed consent. * Anyone pregnant or breastfeeding. * A proximal operator performing a cardiac catheterization procedure where there are not located on the right-side of the patient and/or behind the radiation shield. * Any proximal operator who wishes to use the RADPAD regardless of being in the study/is unwilling to be randomized Exclusion Criteria (Patient Cases): There are no specific exclusion criteria that pertain exclusively to the cardiac catheterization procedure.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Radiation exposure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NYU Langone Hospital - Long Island

    New York, New York, 11501, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.